Anthony Letai
Harvard University(US)Dana-Farber Cancer Institute(US)Dana-Farber/Harvard Cancer Center(US)Center for Systems Biology(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Cell death mechanisms and regulation, Chronic Lymphocytic Leukemia Research, RNA Interference and Gene Delivery, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → The landscape of somatic copy-number alteration across human cancers(2010)4,082 cited
- → An inhibitor of Bcl-2 family proteins induces regression of solid tumours(2005)3,369 cited
- → Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia(2020)2,660 cited
- → Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins(2019)2,015 cited
- → Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia(2018)1,825 cited
- → Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics(2002)1,634 cited